Study details
Enrolling now
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
Stephanie B. Seminara, MD
NCT IDNCT07224490ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
40
Study length
about 4.3 years
Ages
18–60
Locations
1 site in MA
What this study is about
This trial is testing a treatment called kisspeptin in people with or without post-COVID-19 syndrome. The goal is to see how the body responds to this treatment by measuring hormone levels before and after giving it.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Kisspeptin 112-121
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Infectious